B7-H3 targeted antibody-based immunotherapy of malignant diseases

INTRODUCTION: Recent advances in immuno-oncology and bioengineering have rekindled the interest in monoclonal antibody (mAb)-based immunotherapies for malignancies. Crucial for their success is the identification of tumor antigens (TAs) that can serve as targets. B7-H3, a member of the B7 ligand fam...

Full description

Saved in:
Bibliographic Details
Published in:Expert Opin Biol Ther
Main Authors: Michelakos, Theodoros, Kontos, Filippos, Barakat, Omar, Maggs, Luke, Schwab, Joseph H., Ferrone, Cristina R., Ferrone, Soldano
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8087627/
https://ncbi.nlm.nih.gov/pubmed/33301369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2021.1862791
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items